Estados financieros detallados de CalciMedica, Inc. (CALC): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $1.98, CALC presenta beneficios negativos (P/E no significativo) y un ROE del 445.14%. La capitalización bursátil es de $6M.
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $175000 | $303000 | $395000 | $519000 | 0 | 0 | 0 | $46000 |
| Beneficio Bruto | -$175000 | -$303000 | -$395000 | -$519000 | 0 | 0 | 0 | -$46000 |
| I+D | $23.0M | $30.6M | $21.0M | $18.9M | $8.3M | $15.9M | $14.5M | $15.2M |
| Generales y Administrativos | $5.6M | $6.6M | $8.9M | $17.0M | $5.8M | $22.2M | $9.7M | $7.9M |
| Gastos Operativos | $28.6M | $37.2M | $29.4M | $35.4M | $14.2M | $38.1M | $24.2M | $23.1M |
| Beneficio Operativo | -$28.6M | -$37.5M | -$29.8M | -$35.9M | -$14.2M | -$38.1M | -$24.2M | -$23.1M |
| EBITDA | -$28.2M | -$36.7M | -$27.1M | -$35.3M | -$7.6M | -$34.2M | -$13.6M | -$28.1M |
| Gastos por Intereses | 0 | 0 | $143000 | $126000 | $132000 | $110000 | 0 | $1.4M |
| Beneficio Antes de Impuestos | -$28.4M | -$37.0M | -$27.5M | -$35.8M | -$7.8M | -$34.4M | -$13.7M | -$29.6M |
| Impuestos | $13859 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$28.4M | -$37.0M | -$27.5M | -$35.8M | -$7.8M | -$34.4M | -$13.7M | -$29.6M |
| BPA | $-165.50 | $-179.25 | $-367.50 | $-118.30 | $-116.00 | $-38.25 | $-6.10 | $-9.85 |
| BPA Diluido | $-165.50 | $-179.25 | $-367.50 | $-118.30 | $-116.00 | $-38.25 | $-6.10 | $-9.85 |
| Acciones en Circulación (Diluidas) | $171456 | $206619 | $94549 | $302847 | $306990 | $898000 | $2.2M | $3.00B |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | -$7000 | 0 |
| Beneficio Operativo | -$5.6M | -$4.4M | -$5.6M | -$4.0M |
| EBITDA | -$7.5M | -$10.4M | $5.3M | -$7.3M |
| Beneficio Neto | -$7.8M | -$10.8M | $5.0M | -$7.7M |
| BPA | $-2.60 | $-3.60 | $1.55 | $-2.25 |
| BPA Diluido | $-2.60 | $-3.60 | $1.50 | $-2.25 |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $12.8M | $15.9M | $33.4M | $13.4M | $1.3M | $5.5M | $7.9M | $11.5M |
| Inversiones a Corto | 0 | $20.1M | $61.6M | $50.3M | 0 | $5.7M | $10.7M | $1.5M |
| Cuentas por Cobrar | 0 | 0 | 0 | $21000 | $39000 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | -$21000 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $13.4M | $36.3M | $99.2M | $67.1M | $1.7M | $11.6M | $19.7M | $13.5M |
| Inmovilizado Material | $1.5M | $2.0M | $1.9M | $2.0M | $195000 | $167000 | $119000 | $50000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $17.8M | $40.7M | $101.8M | $69.1M | $3.3M | $12.2M | $19.8M | $13.6M |
| Cuentas por Pagar | $2.5M | $4.6M | $2.5M | $527000 | $2.9M | $1.4M | $2.0M | $1.2M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.2M |
| Pasivos Corrientes | $5.8M | $12.3M | $7.0M | $4.1M | $4.8M | $4.0M | $3.7M | $3.8M |
| Deuda a Largo | 0 | 0 | 0 | 0 | $5.2M | 0 | 0 | $8.4M |
| Pasivos Totales | $5.8M | $12.3M | $7.0M | $4.1M | $12.6M | $4.0M | $5.4M | $20.2M |
| Reservas | -$68.8M | -$105.8M | -$133.4M | -$169.2M | -$111.7M | -$146.1M | -$159.8M | -$189.3M |
| Patrimonio Neto | $12.0M | $28.4M | $94.8M | $65.0M | -$9.2M | $8.2M | $14.4M | -$6.6M |
| Deuda Total | $78.8M | $131.4M | 0 | 0 | $5.4M | 0 | 0 | $9.7M |
| Deuda Neta | $66.0M | $95.4M | -$95.0M | -$63.7M | $4.0M | -$11.2M | -$18.7M | -$3.3M |
| Capital Circulante | $7.7M | $24.0M | $92.2M | $63.0M | -$3.0M | $7.6M | $16.0M | $9.7M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $5.5M | $11.5M | $8.2M | $18.6M |
| Activos Totales | $14.9M | $13.6M | $8.6M | $19.5M |
| Pasivos Totales | $15.2M | $20.2M | $9.7M | $14.0M |
| Patrimonio Neto | -$268000 | -$6.6M | -$1.1M | $5.5M |
| Deuda Total | $8.9M | $9.7M | 0 | 0 |
Flujo de Caja (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$28.4M | -$37.0M | -$27.5M | -$35.8M | -$7.8M | -$34.4M | -$13.7M | -$29.6M |
| Amortizaciones | $175000 | $303000 | $395000 | $519000 | $52000 | $58000 | $58000 | $46000 |
| Compensación en Acciones | $348000 | $738000 | $1.8M | $5.4M | $1.8M | $12.0M | $2.3M | $3.0M |
| Cambio en Capital Circulante | -$379000 | $4.9M | -$4.6M | -$1.6M | $605000 | -$267000 | -$495000 | -$623000 |
| Flujo de Caja Operativo | -$28.2M | -$31.2M | -$32.1M | -$31.5M | -$11.8M | -$25.7M | -$21.1M | -$21.2M |
| Inversiones (CapEx) | -$1.5M | -$605000 | -$1.0M | -$488000 | -$4000 | -$78000 | -$8000 | -$28000 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$29.7M | -$31.8M | -$33.1M | -$32.0M | -$11.8M | -$25.8M | -$21.2M | -$21.2M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$4.8M | -$4.9M | -$4.9M | -$4.6M |
| Inversiones (CapEx) | -$8000 | -$6000 | 0 | 0 |
| Flujo de Caja Libre | -$4.8M | -$4.9M | -$4.9M | -$4.6M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $625000 | $622000 | $561000 | $540000 |
Crecimiento y Márgenes (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | -30.5% | +25.7% | -30.1% | +78.2% | -339.1% | +60.1% | -115.8% |
| Crecimiento BPA (anual) | | -8.3% | -105.0% | +67.8% | +1.9% | +67.0% | +84.1% | -61.5% |
| Cambio en Acciones (anual) | | +20.5% | -54.2% | +220.3% | +1.4% | +192.5% | +150.5% | +133382.4% |
| Crecimiento FCF (anual) | | -7.2% | -4.0% | +3.3% | +63.2% | -119.4% | +18.0% | -0.2% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-173.09 | $-154.00 | $-349.95 | $-105.62 | $-38.31 | $-28.74 | $-9.41 | $-0.01 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $171456 | $206619 | $94549 | $302847 | $306990 | $898000 | $2.2M | $3.00B |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | 445.14% |
| Rentabilidad sobre capital invertido | -209.07% |
| Rentabilidad sobre activos | -217.51% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | -1.46 |
| Ratio corriente | 3.58 |
Ratios Clave (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -0.18 | -0.16 | -0.08 | -0.25 | -0.25 | -0.37 | -2.90 | -3.35 |
| P/VC | 0.42 | 0.21 | 0.03 | 0.14 | -0.97 | 1.57 | 2.76 | -14896.04 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |